{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:09:39Z","timestamp":1790701779480,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["NO. 320.6750.2025-06-150"],"award-info":[{"award-number":["NO. 320.6750.2025-06-150"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["NO. CY2024-MS-B18"],"award-info":[{"award-number":["NO. CY2024-MS-B18"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","award":["No. 26YFWA011"],"award-info":[{"award-number":["No. 26YFWA011"]}],"id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejso.2026.112171","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:58:48Z","timestamp":1790175528000},"page":"112171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of circulating tumor DNA in treated gastric cancer patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Yuze","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jize","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangzu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.112171_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024 CA","volume":"74","author":"Jemal","year":"2024","journal-title":"A Cancer Journal for Clinicians"},{"issue":"8","key":"10.1016\/j.ejso.2026.112171_bib3","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.3390\/ijms23084441","article-title":"Circulating Tumor DNA in precision oncology and its applications in colorectal cancer","volume":"23","author":"Arisi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2016.06.033","article-title":"Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study","volume":"590","author":"Yao","year":"2016","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.ejso.2026.112171_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"10.1016\/j.ejso.2026.112171_bib6","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.3390\/cancers17223692","article-title":"Circulating Tumor DNA (ctDNA) in gastroesophageal adenocarcinoma (GEA): evidence and emerging applications","volume":"17","author":"Sahwan","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.112171_bib7","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.ejso.2026.112171_bib8","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1245\/s10434-025-17397-4","article-title":"Utilizing combined circulating tumor DNA and tumor markers to evaluate neoadjuvant therapy response and predict recurrence in patients with locally advanced gastric cancer","volume":"32","author":"Zhu","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112171_bib9","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/1878-0261.13481","article-title":"Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II\/III gastric cancer","volume":"17","author":"Zhang","year":"2023","journal-title":"Mol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.112171_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41419-020-2531-z","article-title":"Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-020-01274-7","article-title":"The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors","volume":"19","author":"Jin","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejso.2026.112171_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112171_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70065","article-title":"Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13643-025-02752-z","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance","volume":"14","author":"Tierney","year":"2025","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejso.2026.112171_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231225038","article-title":"Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis","volume":"16","author":"Yuan","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib16","article-title":"Plasma circulating tumor DNA unveils the efficacy of PD-1 inhibitors and chemotherapy in advanced gastric cancer","volume":"14","author":"Jiang","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ejso.2026.112171_bib17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10120-025-01621-x","article-title":"Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer","volume":"28","author":"He","year":"2025","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2026.112171_bib18","series-title":"Cochrane handbook for systematic reviews of interventions","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2019"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10120-024-01556-9","article-title":"Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer","volume":"28","author":"Iden","year":"2025","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib22","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1038\/s41467-025-62056-7","article-title":"Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study","volume":"16","author":"Zaanan","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s43856-025-00867-x","article-title":"Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma","volume":"5","author":"Tougeron","year":"2025","journal-title":"Commun Med"},{"issue":"2","key":"10.1016\/j.ejso.2026.112171_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41591-023-02758-x","article-title":"Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial","volume":"30","author":"Verschoor","year":"2024","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ejso.2026.112171_bib23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s13258-023-01412-7","article-title":"Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer","volume":"45","author":"Zhou","year":"2023","journal-title":"Genes Genomics"},{"issue":"12","key":"10.1016\/j.ejso.2026.112171_bib24","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cac2.12494","article-title":"Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer","volume":"43","author":"Yuan","year":"2023","journal-title":"Cancer Commun"},{"key":"10.1016\/j.ejso.2026.112171_bib28","article-title":"Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers","volume":"6","author":"Huffman","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41467-020-14310-3","article-title":"White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer","volume":"11","author":"Leal","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ejso.2026.112171_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.254","article-title":"Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies","volume":"10","author":"Zhang","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ejso.2026.112171_bib19","series-title":"Newcastle-Ottawa quality assessment scale cohort studies","author":"Wells","year":"2014"},{"key":"10.1016\/j.ejso.2026.112171_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2026.112171_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1055968","article-title":"Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients","volume":"12","author":"Chan","year":"2023","journal-title":"Front Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2026.112171_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911521","article-title":"Tumor-informed approach improved ctDNA detection rate in resected pancreatic cancer","volume":"23","author":"Watanabe","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ejso.2026.112171_bib32","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.18632\/oncotarget.14064","article-title":"Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"issue":"48","key":"10.1016\/j.ejso.2026.112171_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036228","article-title":"Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: a systematic review and meta-analysis","volume":"102","author":"Mi","year":"2023","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.ejso.2026.112171_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/1354750X.2023.2201664","article-title":"Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis","volume":"28","author":"Min","year":"2023","journal-title":"Biomarkers"},{"issue":"7","key":"10.1016\/j.ejso.2026.112171_bib35","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1097\/JS9.0000000000001373","article-title":"Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis","volume":"110","author":"Zhang","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.112171_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102999","article-title":"Circulating tumor DNA as prognostic marker in patients with metastatic colorectal cancer undergoing systemic therapy: a systematic review and meta-analysis","volume":"139","author":"Holz","year":"2025","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12916-023-03181-2","article-title":"Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.ejso.2026.112171_bib38","article-title":"Predictive effectiveness of circulating tumor DNA in recurrent early-stage non-small cell lung cancer: an updated meta-analysis","volume":"9","author":"Lu","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejso.2026.112171_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100441","article-title":"Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis","volume":"10","author":"Steiniche","year":"2025","journal-title":"J Liq Biopsy"},{"issue":"3","key":"10.1016\/j.ejso.2026.112171_bib40","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-023-14751-2","article-title":"Initial report: personalized circulating tumor DNA and survival in patients with resectable pancreatic cancer","volume":"31","author":"Eckhoff","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-025-01986-y","article-title":"Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis","volume":"27","author":"Zhang","year":"2025","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2026.112171_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1655415","article-title":"Circulating DNA tumor fraction as a biomarker for advanced breast cancer","volume":"15","author":"Cybulla","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005924","article-title":"Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy","volume":"11","author":"Sivapalan","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.112171_bib44","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.3390\/ijms24044014","article-title":"Metastatic melanoma: liquid biopsy as a new precision medicine approach","volume":"24","author":"Ricciardi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ejso.2026.112171_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:49:53Z","timestamp":1790700593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326007900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0748798326007900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112171","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of circulating tumor DNA in treated gastric cancer patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112171"}}